Sinclair Pharma PLC Result of AGM (3989D)
26 April 2017 - 7:50PM
UK Regulatory
TIDMSPH
RNS Number : 3989D
Sinclair Pharma PLC
26 April 2017
Sinclair Pharma plc
Result of AGM
London, 26 April 2017 Sinclair Pharma plc (SPH.L), ("Sinclair")
the international Aesthetics company, announces that all
resolutions put to its Annual General Meeting held earlier today
were duly passed.
For further information please contact:
Sinclair Pharma plc Tel: +44 (0) 20 7467
6920
Chris Spooner
Alan Olby
Andy Crane
Peel Hunt LLP (NOMAD and Tel: +44 (0) 20 7418
Joint Broker) 8900
James Steel
Oliver Jackson
RBC Capital Markets (Joint Tel: +44 (0) 20 7653
Broker) 4000
Marcus Jackson
Laura White
Media enquiries
FTI Consulting Tel: +44 (0) 203 727
1000
Ben Atwell
Brett Pollard
Stephanie Cuthbert
Notes to Editors:
About Sinclair Pharma plc
Sinclair Pharma plc is an international company operating in the
fast growth, high gross margin, global aesthetics market. Sinclair
has built a strong portfolio of differentiated, complementary
aesthetics technologies, which are experiencing significant growth,
targeting unmet clinical needs for effective, high quality, longer
duration, natural looking and minimally-invasive treatments. The
Company is planning entry to multiple new geographic markets and
line extension launches over the next few years. Sinclair has an
established sales and marketing presence in the leading EU markets
and Brazil, and a network of international distributors.
For more information, please visit
www.sinclairpharma.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGOKADQCBKKCQB
(END) Dow Jones Newswires
April 26, 2017 05:50 ET (09:50 GMT)
Sinclair Pharma (LSE:SPH)
Historical Stock Chart
From Apr 2024 to May 2024
Sinclair Pharma (LSE:SPH)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Sinclair Pha (London Stock Exchange): 0 recent articles
More Sinclair Pha News Articles